Identifying Mutator Phenotypes Among Fluoroquinolone-resistant Strains of Streptococcus Pneumoniae Using Fluctuation Analysis

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 2007 Aug 1

PMID 17664329

Citations 15

Authors

Carolyn V Gould

Paul D Sniegowski

Mikhail Shchepetov

Joshua P Metlay

Jeffrey N Weiser

Affiliations

Soon will be listed here.

Abstract

The occurrence of mutator phenotypes among laboratory-generated and clinical levofloxacin-resistant strains of Streptococcus pneumoniae was determined using fluctuation analysis. The in vitro selection for levofloxacin-resistant mutants of strain D39, each with point mutations in both gyrA and parC or parE, was not associated with a significant change in the mutation rate. Two of eight clinical isolates resistant to levofloxacin (MIC, >8 microg/ml) had estimated mutation rates of 1.2 x 10(-7) and 9.4 x 10(-8) mutations per cell division, indicating potential mutator phenotypes, compared to strain D39, which had an estimated mutation rate of 1.4 x 10(-8) mutations per cell division. The levofloxacin-resistant isolates with the highest mutation rates showed evidence of dysfunctional mismatch repair and contained missense mutations in mut genes at otherwise highly conserved sites. The association of hypermutability in levofloxacin-resistant S. pneumoniae clinical isolates with mutations in DNA mismatch repair genes provides further evidence that mismatch repair mutants may have a selective advantage in the setting of antibiotic pressure, facilitating the development of further antibiotic resistance.

Citing Articles

The (A)/(D)-carrying streptococcal prophage Φ1207.3 encodes an SOS-like system, induced by UV-C light, responsible for increased survival and increased mutation rate.

Fox V, Santoro F, Apicella C, Diaz-Diaz S, Rodriguez-Martinez J, Iannelli F J Bacteriol. 2023; 205(9):e0019123.

PMID: 37695857 PMC: 10521357. DOI: 10.1128/jb.00191-23.

Allele-specific collateral and fitness effects determine the dynamics of fluoroquinolone resistance evolution.

Liakopoulos A, Aulin L, Buffoni M, Fragkiskou E, van Hasselt J, Rozen D Proc Natl Acad Sci U S A. 2022; 119(18):e2121768119.

PMID: 35476512 PMC: 9170170. DOI: 10.1073/pnas.2121768119.

The fitness cost of mismatch repair mutators in Saccharomyces cerevisiae: partitioning the mutational load.

Galeota-Sprung B, Guindon B, Sniegowski P Heredity (Edinb). 2019; 124(1):50-61.

PMID: 31515531 PMC: 6906417. DOI: 10.1038/s41437-019-0267-2.

The Mutator Phenotype: Adapting Microbial Evolution to Cancer Biology.

Natali F, Rancati G Front Genet. 2019; 10:713.

PMID: 31447882 PMC: 6691094. DOI: 10.3389/fgene.2019.00713.

Adaptive tuning of mutation rates allows fast response to lethal stress in .

Swings T, Van den Bergh B, Wuyts S, Oeyen E, Voordeckers K, Verstrepen K Elife. 2017; 6.

PMID: 28460660 PMC: 5429094. DOI: 10.7554/eLife.22939.

References

Hooper D . Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis. 2001; 32 Suppl 1:S9-S15. DOI: 10.1086/319370. View

Tiraby J, Fox M . Marker discrimination in transformation and mutation of pneumococcus. Proc Natl Acad Sci U S A. 1973; 70(12):3541-5. PMC: 427276. DOI: 10.1073/pnas.70.12.3541. View

Samrakandi M, Pasta F . Hyperrecombination in Streptococcus pneumoniae depends on an atypical mutY homologue. J Bacteriol. 2000; 182(12):3353-60. PMC: 101888. DOI: 10.1128/JB.182.12.3353-3360.2000. View

LEA D, COULSON C . The distribution of the numbers of mutants in bacterial populations. J Genet. 2014; 49(3):264-85. DOI: 10.1007/BF02986080. View

Sniegowski P, Gerrish P, Lenski R . Evolution of high mutation rates in experimental populations of E. coli. Nature. 1997; 387(6634):703-5. DOI: 10.1038/42701. View

Pericone C, Bae D, Shchepetov M, McCool T, Weiser J . Short-sequence tandem and nontandem DNA repeats and endogenous hydrogen peroxide production contribute to genetic instability of Streptococcus pneumoniae. J Bacteriol. 2002; 184(16):4392-9. PMC: 135236. DOI: 10.1128/JB.184.16.4392-4399.2002. View

Roman F, Canton R, Perez-Vazquez M, Baquero F, Campos J . Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains. J Clin Microbiol. 2004; 42(4):1450-9. PMC: 387613. DOI: 10.1128/JCM.42.4.1450-1459.2004. View

Sanders C . Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones. Clin Infect Dis. 2001; 32 Suppl 1:S1-8. DOI: 10.1086/319369. View

Balsalobre L, Ferrandiz M, Linares J, Tubau F, Campa A . Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae. Antimicrob Agents Chemother. 2003; 47(7):2072-81. PMC: 161831. DOI: 10.1128/AAC.47.7.2072-2081.2003. View

10.

Heffelfinger J, Dowell S, Jorgensen J, Klugman K, Mabry L, Musher D . Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med. 2000; 160(10):1399-408. DOI: 10.1001/archinte.160.10.1399. View

11.

Del Campo R, Morosini M, De la Pedrosa E, Fenoll A, Munoz-Almagro C, Maiz L . Population structure, antimicrobial resistance, and mutation frequencies of Streptococcus pneumoniae isolates from cystic fibrosis patients. J Clin Microbiol. 2005; 43(5):2207-14. PMC: 1153755. DOI: 10.1128/JCM.43.5.2207-2214.2005. View

12.

Shaver A, Sniegowski P . Spontaneously arising mutL mutators in evolving Escherichia coli populations are the result of changes in repeat length. J Bacteriol. 2003; 185(20):6076-82. PMC: 225017. DOI: 10.1128/JB.185.20.6076-6082.2003. View

13.

Pan X, Ambler J, Mehtar S, Fisher L . Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob Agents Chemother. 1996; 40(10):2321-6. PMC: 163528. DOI: 10.1128/AAC.40.10.2321. View

14.

Mandell L, Bartlett J, Dowell S, File Jr T, Musher D, Whitney C . Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 2003; 37(11):1405-33. PMC: 7199894. DOI: 10.1086/380488. View

15.

Rosche W, Foster P . Determining mutation rates in bacterial populations. Methods. 1999; 20(1):4-17. PMC: 2932672. DOI: 10.1006/meth.1999.0901. View

16.

Mao E, Lane L, Lee J, Miller J . Proliferation of mutators in A cell population. J Bacteriol. 1997; 179(2):417-22. PMC: 178711. DOI: 10.1128/jb.179.2.417-422.1997. View

17.

LeClerc J, Li B, Payne W, Cebula T . High mutation frequencies among Escherichia coli and Salmonella pathogens. Science. 1996; 274(5290):1208-11. DOI: 10.1126/science.274.5290.1208. View

18.

Luria S, DELBRUCK M . Mutations of Bacteria from Virus Sensitivity to Virus Resistance. Genetics. 1943; 28(6):491-511. PMC: 1209226. DOI: 10.1093/genetics/28.6.491. View

19.

Orlen H, Hughes D . Weak mutators can drive the evolution of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother. 2006; 50(10):3454-6. PMC: 1610101. DOI: 10.1128/AAC.00783-06. View

20.

Gillespie S, Voelker L, Ambler J, Traini C, Dickens A . Fluoroquinolone resistance in Streptococcus pneumoniae: evidence that gyrA mutations arise at a lower rate and that mutation in gyrA or parC predisposes to further mutation. Microb Drug Resist. 2003; 9(1):17-24. DOI: 10.1089/107662903764736300. View